DP-VPA D-Pharm

Research output: Contribution to journalArticle

18 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)921-923
Number of pages3
JournalCurrent Opinion in Investigational Drugs
Volume3
Issue number6
StatePublished - Jun 1 2002

Fingerprint

Phase II Clinical Trials
Preclinical Drug Evaluations
Prodrugs
Valproic Acid
Structure-Activity Relationship
Migraine Disorders
Bipolar Disorder
Epilepsy
DP-VPA

ASJC Scopus subject areas

  • Pharmacology

Cite this

DP-VPA D-Pharm. / Labiner, David M.

In: Current Opinion in Investigational Drugs, Vol. 3, No. 6, 01.06.2002, p. 921-923.

Research output: Contribution to journalArticle

@article{78a94a426000446dae3e37bf7a95a478,
title = "DP-VPA D-Pharm",
author = "Labiner, {David M}",
year = "2002",
month = "6",
day = "1",
language = "English (US)",
volume = "3",
pages = "921--923",
journal = "Current Opinion in Investigational Drugs",
issn = "1354-3784",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - DP-VPA D-Pharm

AU - Labiner, David M

PY - 2002/6/1

Y1 - 2002/6/1

UR - http://www.scopus.com/inward/record.url?scp=0036628434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036628434&partnerID=8YFLogxK

M3 - Article

C2 - 12137414

AN - SCOPUS:0036628434

VL - 3

SP - 921

EP - 923

JO - Current Opinion in Investigational Drugs

JF - Current Opinion in Investigational Drugs

SN - 1354-3784

IS - 6

ER -